mTOR inhibitors in advanced renal cell carcinomas: From biology to clinical practice
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference78 articles.
1. Estimates of cancer incidence and mortality in Europe in 2008;Ferlay;The European Journal of Cancer,2010
2. Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?;Corradetti;Oncogene,2006
3. Angiogenesis in health and disease;Carmeliet;Nature Medicine,2003
4. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma;Rini;Journal of Clinical Oncology,2005
5. Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens;Amato;Annals of Oncology,2005
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. NAA10 gene expression is associated with mesenchymal transition, dedifferentiation, and progression of clear cell renal cell carcinoma;Pathology - Research and Practice;2024-03
2. PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth in vitro and in vivo;Aging;2020-05-18
3. The tumor suppressor NDRG2 cooperates with an mTORC1 inhibitor to suppress the Warburg effect in renal cell carcinoma;Investigational New Drugs;2019-08-28
4. Patient-derived xenograft models to optimize kidney cancer therapies;Translational Andrology and Urology;2019-05
5. Systemic therapy of metastatic renal cell carcinoma: Review of the current literature;Urologia Journal;2018-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3